Published in: The Business Standard
Date: 22 July, 2021

“After assessing the available data, PRAC considered that a causal relationship between Covid-19 vaccine Janssen and GBS is possible,” the European Medicines Agency said, referring to its safety committee, PRAC

Europe’s medicines regulator said on Thursday it had added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson’s Covid-19 vaccine after it reviewed 108 cases reported worldwide.

“After assessing the available data, PRAC considered that a causal relationship between Covid-19 vaccine Janssen and GBS is possible,” the European Medicines Agency said, referring to its safety committee, PRAC.

Source: https://www.tbsnews.net/coronavirus-chronicle/eu-lists-rare-nerve-disorder-side-effect-jj-covid-19-vaccine-277795